Chronic Traumatic Encephalopathy

Chronic Traumatic Encephalopathy (CTE) is a progressive degenerative disease that occurs in individuals that suffer repetitive brain trauma. Discover the latest research on traumatic encephalopathy here.

April 8, 2021

Validity of the 2014 traumatic encephalopathy syndrome criteria for CTE pathology.

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Jesse MezAnn C McKee
April 3, 2021

Overview of Traumatic Brain Injury in American Football Athletes.

Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine
Jose A CansecoAlexander R Vaccaro
April 2, 2021
Open Access

The Delayed Neuropathological Consequences of Traumatic Brain Injury in a Community-Based Sample.

Frontiers in Neurology
Nadia PostupnaC Dirk Keene
April 2, 2021

Player age and initial helmet contact among American football players.

The American Journal of Emergency Medicine
David X WangDavid Milzman
March 24, 2021
Open Access

Space-occupying brain lesions, trauma-related tau astrogliopathy, and ARTAG: a report of two cases and a literature review.

Acta Neuropathologica Communications
Adam D BachstetterPeter T Nelson
March 23, 2021

Hevin-calcyon interaction promotes synaptic reorganization after brain injury.

Cell Death and Differentiation
Jong-Heon KimKyoungho Suk
March 16, 2021
Open Access

The Impact of the Concussion Crisis on Safeguarding in Sport.

Frontiers in Sports and Active Living
Dominic Malcolm
March 13, 2021
Open Access

Frequency and Predictors of Traumatic Encephalopathy Syndrome in a Prospective Cohort of Retired Professional Athletes.

Frontiers in Neurology
Jeff SchaffertC Munro Cullum
March 12, 2021
Open Access

Chronic Traumatic Encephalopathy (CTE)-Type Neuropathology in a Young Victim of Domestic Abuse.

Journal of Neuropathology and Experimental Neurology
Travis DanielsenCharles L White
March 9, 2021
Open Access

The Immune System's Role in the Consequences of Mild Traumatic Brain Injury (Concussion).

Frontiers in Immunology
Laura N VerboonAndrew D Greenhalgh
March 5, 2021
Open Access

Inter-individual variability in disease expression: the Tudor-Churchill spectrum.

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Donald F Weaver
March 3, 2021
Open Access

COllaborative Neuropathology NEtwork Characterizing ouTcomes of TBI (CONNECT-TBI).

Acta Neuropathologica Communications
Douglas H SmithWilliam Stewart
March 3, 2021
Open Access

Tau Imaging in Head Injury.

PET Clinics
Cyrus AyubchaMona-Elisabeth Revheim
February 27, 2021

A mesoscale finite element modeling approach for understanding brain morphology and material heterogeneity effects in chronic traumatic encephalopathy.

Computer Methods in Biomechanics and Biomedical Engineering
A BakhtiarydavijaniR K Prabhu
February 24, 2021

Chronic traumatic encephalopathy.

Jacques HugonClaire Paquet
February 22, 2021
Open Access

The Second NINDS/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy.

Journal of Neuropathology and Experimental Neurology
Kevin F BieniekTBI/CTE Research Group
February 18, 2021

Neurological associations of SARS-CoV-2 infection: A Systematic Review.

CNS & Neurological Disorders Drug Targets
Amaan Javed

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved